Search results
Vir Biotechnology (NASDAQ:VIR) Trading Down 8%
ETF DAILY NEWS· 19 hours agoVir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report)’s stock price was down 8% during mid-day trading on Friday . The stock traded as low as $11.02 and last traded at $11.02 ...
Vir stock gains on hepatitis drug data (NASDAQ:VIR)
Seeking Alpha· 5 days agoVir Biotechnology (VIR) stock gains as its hepatitis therapy tobevibart developed with Xencor shows early signs of efficacy in a Phase 2 trial. Read more...
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
Zacks via Yahoo Finance· 5 days agoThe iShares Biotechnology ETF (IBB) was launched on 02/05/2001, and is a smart beta exchange traded...
Vir Biotechnology (VIR) Up on Positive Data From HDV Study
Zacks via Yahoo Finance· 3 days agoVir Biotechnology (VIR) rises on upbeat data from its phase II study evaluating tobevibart and...
National Security Commission on Emerging Biotechnology Announces Introduction of Agricultural Bills...
JD Supra· 4 days agoSenators Alex Padilla (D-CA) and Todd Young (R-IN) and Representatives Stephanie Bice (R-OK) and Ro Khanna (D-CA) — for introducing the legislative recommendations from its first report. The ...
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
Zacks via Yahoo Finance· 6 days agoThe First Trust NYSE Arca Biotechnology ETF (FBT) was launched on 06/19/2006, and is a passively...
CollPlant Biotechnologies First Quarter 2024 Earnings: Misses Expectations
Simply Wall St. via Yahoo Finance· 5 days agoCollPlant Biotechnologies (NASDAQ:CLGN) First Quarter 2024 Results Key Financial Results Revenue:...
iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Scotia Capital Inc.
ETF DAILY NEWS· 7 days agoScotia Capital Inc. lessened its stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 6.7% during the 4th quarter, according to its most recent 13F filing with ...
MAIA Biotechnology reports promising Phase 2 trial results By Investing.com
Investing.com· 5 days agoMAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company, has...
MilliporeSigma Announces Siren Biotechnology As Winner Of Its North American Advance Biotech Grant
BioresearchOnline· 6 days agoMilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany,...